Akamis Bio

Abingdon, United Kingdom · Founded 2006 · Privately Held (backing)

Operator of a clinical-stage oncology company intended to develop cancer gene therapies. Akamis Bio is based in Abingdon, United Kingdom and was founded in 2006. Its last reported valuation was $145 million in Jan 2023. It has raised $185 million.

Last reported valuation
$145.3M
Oct 2026
Priced at
—
Total raised
$184.6M
Last round
—

Who backs Akamis Bio?

25 investors
InvestorType
Salica InvestmentsVenture capital
ARCH Venture PartnersVenture capital
Bristol-Myers Squibb—
Revelation PartnersVenture capital
SR One Capital ManagementOther
Mercia Asset ManagementVenture capital
Woodford Investment ManagementOther
Invesco Asset ManagementAsset manager
Rosetta Capital (UK)Venture capital
LundbeckfondenOther
+ 15 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Akamis Bio investors

25 investors are on record for Akamis Bio, including Salica Investments, ARCH Venture Partners, Bristol-Myers Squibb and Revelation Partners. By type, the record holds 5 venture capital firms and 1 asset manager.

Free account
More of Akamis Bio with a free account
  • ·The complete investor list: 25 names
  • ·Watch Akamis Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 25 firms already write checks for companies like Akamis Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View